The article says bulk plaque remains a plausible but unlikely solution. That is contradictory: that solution is plausible. Regardless, that is not the most salient issue with beta amyloid plaque approach: plaque is downstream and removing it (soluble or insoluble forms) does not result in clinically meaningful impact on AD patients.
News 
Market Data 
Discover 
